News
How Pharmaceutical Manufacturers Validate GMP Cleaning Protocols: ATP Bioluminescence Testing for Contamination Control
You know how quickly a single overlooked residue can turn into a recalled batch or a Form 483 citation. Good manufacturing practice cleaning validation exists precisely because visual inspection alone cannot catch invisible protein or chemical carryover between production...
News
Why Specialty Pharmacy Accreditation Matters: Standards for Pharmaceutical Distribution and Patient Outcomes
In This Article
This article contains:
What Is a Specialty Pharmacy and Why Does It Need Specific Standards?
The Core Pillars of Pharmacy Accreditation
An Overview of Leading Accreditation Bodies
The Next Frontier: Why AI in Health Care Requires a...
News
Strategic Alliance Boosts Nutraceutical Innovation and Trade
The Organic & Natural Health Association has officially entered into a strategic partnership with the Shellac & Forest Products Export Promotion Council (SHEFEXIL) to bolster scientific collaboration and trade within the sector. This agreement, finalized this week, represents the...
Business & Industry
Australia Reviews PBS Pricing Framework Amid Industry Dispute Over Benchmarks
The Australian government is currently navigating a significant period of reassessment regarding its national drug reimbursement model, as tensions between global pharmaceutical manufacturers and health regulators reach a critical juncture. At the center of this dispute is the Pharmaceutical...
Business & Industry
SK Telecom and SK Biopharmaceuticals Identify Lead Compounds for Cancer Treatment via AI
SK Telecom and SK Biopharmaceuticals have announced the successful identification of early lead compounds designed for the development of targeted therapies for intractable cancers. By leveraging AI Drug Discovery, the joint research team discovered two specific substances capable of...
Business & Industry
Senate Investigates Foreign Control and Ownership within the Pharmaceutical Sector
The Senate Special Committee on Aging is preparing to conduct a hearing titled "Behind The Label: Focusing On Foreign Ownership And Control In America's Drug Supply Chain." Scheduled for Wednesday, July 15, the session arrives as the industry faces...
Business & Industry
Germany to Double Mandatory Drug Rebates to 15.5 Percent
As European nations seek to stabilize their national health systems, the resulting regulatory changes are prompting a reassessment of market priority and supply chain reshoring. In a significant escalation of this trend, German lawmakers have finalized a sweeping health...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read